A Systematic Approach for Engineering PDMS Microparticles via Plasma Polymerization to Enhance Cell Compatibility and Recombinant Protein Expression in Eukaryotic Cells
The use of microparticles for high-cell-density cultures has been extensively studied. While various polymers have been used for microparticle preparation, each polymer differs, and a unique methodology for fabrication and surface modification is needed. In this context, we present a systematic approach to developing a polymer microparticle system for protein expression. This approach starts with understanding PDMS and plasma polymerization in two-dimensional (2D) to assess their compatibility for HEK293 and Sf9 insect cells. To transition to three-dimensional (3D), we optimized a three-step plasma polymerization process to overcome shadowing during deposition on spherical geometries. Finally, we validated plasma-polymerized 3D PDMS microparticles for protein expression using Sf9 insect cells. This framework provides a robust template for developing and implementing a microparticle and a coating method for recombinant protein expression.
Authors
- Lopamudra Giri (ORCID: https://orcid.org/0000-0002-2352-7919)
- Jagadeesh Mahadevan (ORCID: https://orcid.org/0000-0003-0814-6437)
- Hüseyin Sümer (ORCID: https://orcid.org/0000-0001-9413-5579)
- Karyn L. Jarvis (ORCID: https://orcid.org/0000-0003-1370-5045)
- Kishalay Mitra (ORCID: https://orcid.org/0000-0001-5660-6878)
- Simon Edward Moulton (ORCID: https://orcid.org/0000-0002-8320-3852)
Institutions
- Swinburne University of Technology (AU)
- Indian Institute of Technology Hyderabad (IN)
Publication Details
- Journal
- ACS Applied Bio Materials
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1021/acsabm.6c01759
- Primary Topic
- Viral Infectious Diseases and Gene Expression in Insects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Indian Institute of Technology Hyderabad
- Department of Biotechnology, Ministry of Science and Technology, India
- Swinburne University of Technology
- Medical Research Future Fund